.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
McKinsey
Express Scripts
Cantor Fitzgerald
Cerilliant
Queensland Health
Covington
Novartis
Daiichi Sankyo

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,802,735

« Back to Dashboard

Which drugs does patent 8,802,735 protect, and when does it expire?


Patent 8,802,735 protects AUBAGIO and is included in one NDA.

This patent has forty-one patent family members in thirty-one countries.

Summary for Patent: 8,802,735

Title:(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
Inventor(s): Hauck; Gerrit (Frankfurt am Main, DE)
Assignee: Sanofi (Paris, FR)
Application Number:13/422,494
Patent Claim Types:
see list of patent claims
Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis Us
AUBAGIO
teriflunomide
TABLET;ORAL202992-001Sep 12, 2012RXYesNo► Subscribe► SubscribeY
Sanofi Aventis Us
AUBAGIO
teriflunomide
TABLET;ORAL202992-002Sep 12, 2012RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,802,735

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
09290716Sep 18, 2009

International Patent Family for Patent: 8,802,735

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Peru20312015► Subscribe
Peru14782012► Subscribe
New Zealand617025► Subscribe
New Zealand598744► Subscribe
Malaysia155613► Subscribe
Mexico336663► Subscribe
Mexico2012003122► Subscribe
Morocco33585► Subscribe
Lithuania2477611► Subscribe
South Korea101547880► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
US Army
Medtronic
AstraZeneca
Federal Trade Commission
Deloitte
Express Scripts
Merck
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot